Abstract:Overdose of acetaminophen (APAP), the most widely used analgesic, results in acute liver failure. We have investigated the role of a post‐translational modification of proteins called O‐GlcNAcylation in pathogenesis of APAP‐induced liver injury, where a single β‐D‐N‐acetylglucosamine (O‐GlcNAc) moiety is added to proteins by an enzyme called O‐GlcNAc transferase (OGT) and removed by an enzyme called O‐GlcNAcase (OGA). Male C57BL/6J mice were treated with 300 mg/kg APAP followed by Thiamet‐G (TMG, 400 mg/kg) a specific inhibitor of OGA that induces O‐GlcNAcylation, 1.5 hr after APAP administration. Progression of liver injury was studied over a time course of 0 to 24 hr. TMG treatment resulted in significant increase in hepatic O‐GlcNAc. The mice treated with 400 mg/kg TMG exhibited significantly higher APAP‐induced liver injury as indicated by increase in serum transaminase levels and histopathological analysis, as well as a prolonged JNK activation. Treatment with TMG did not affect hepatic CYP2E1 levels, APAP protein adduct formation, APAP induced mitochondrial damage, hepatic glutathione (GSH), or depletion of GSH after APAP treatment. C57BL/6J mice were also treated with 50 mg/kg TMG every other day for 15 days followed by 300 mg/kg APAP and sacrificed at 24 hr. Mice treated with 50 mg/kg TMG showed a similar increase in APAP‐induced liver injury. Next we used hepatocyte specific OGT knockout mice (OGT KO), which have decreased O‐GlcNAcylation to study APAP toxicity. OGT KO and WT control mice were treated with 300 mg/kg and sacrificed on a timecourse from 0–24 hr. OGT KO mice showed dramatic decrease in liver injury as compared to WT mice. APAP protein adducts was significantly decreased in OGT KO mice when compared to WT control mice. There was no difference CYP2E1 activity showing that OGT KO did not alter cytochrome P450 levels and alter APAP metabolism. Hepatic GSH depletion was equal in OGT KO and WT mice but GSH was rapidly replenished by 6hr after APAP treatment in OGT KO mice, while WT mice did not fully replenish until 24hr post APAP. Taken together, these data indicate that induction in cellular O‐GlcNAcylation exacerbates and decrease in O‐GlcNAcylation protects from APAP induced liver injury. These studies have identified a novel mechanism of pathogenesis of acute liver injury induced by APAP and highlighted a novel therapeutic target for acute liver failure. Support or Funding Information R01DK098414

Chitohexaose protects against acetaminophen-induced hepatotoxicity in mice

Single-cell RNA Sequencing Reveals the Dynamics of Hepatic Non-Parenchymal Cells in Autoprotection Against Acetaminophen-Induced Hepatotoxicity

Bifidobacterium Longum R0175 Protects Mice Against APAP-induced Liver Injury by Modulating the Nrf2 Pathway.

Inhibiting Hepatocyte Uric Acid Synthesis and Reabsorption Ameliorates Acetaminophen-Induced Acute Liver Injury in Mice.

Suppression of glomerular damage and apoptosis and biomarkers of acute kidney injury induced by acetaminophen toxicity using a combination of resveratrol and quercetin

CXCL16 deficiency attenuates acetaminophen-induced hepatotoxicity through decreasing hepatic oxidative stress and inflammation in mice

25-Hydroxycholesterol 3-Sulfate Recovers Acetaminophen Induced Acute Liver Injury via Stabilizing Mitochondria in Mouse Models

Hepatic Overexpression of Annexin A1 and A2 in Thioacetamide-Primed Mice Protects Them Against Acetaminophen-Induced Liver Failure and Death

<i>Akkermansia muciniphila</i> Ameliorates Acetaminophen-Induced Liver Injury by Regulating Gut Microbial Composition and Metabolism

Wnt/β-Catenin Signaling Drives Thioacetamide-Mediated Heteroprotection Against Acetaminophen-Induced Lethal Liver Injury

Procyanidins Ameliorate Acetaminophen-induced Acute Liver Injury via Activating the Nrf-2/SOD-1 Signal Pathway

Design of anti-inflammatory heparan sulfate to protect against acetaminophen-induced acute liver failure

Carbon monoxide releasing molecule A-1 attenuates acetaminophen-mediated hepatotoxicity and improves survival of mice by induction of Nrf2 and related genes

Effect of trifluoperazine on toxicity, HIF-1α induction and hepatocyte regeneration in acetaminophen toxicity in mice

[Protective Effects and Possible Mechanisms of Hepatic Fibrosis Against APAP-induced Lethal Injury].

Role of Hepatic O‐GlcNAcylation on Acetaminophen‐Induced Liver Injury

Post-treatment with Glycyrrhizin Can Attenuate Hepatic Mitochondrial Damage Induced by Acetaminophen in Mice

Hepato-Protective Effect Of Ginsenosides From The Fruits Of Panax Ginseng Against Acetaminophen-Induced Liver Damage In Mice

Ethyl gallate concurrent administration protects against acetaminophen‐induced acute liver injury in mice: An in vivo and in silico approach

Modulation of HMGB1 Release in APAP-Induced Liver Injury: A Possible Strategy of Chikusetsusaponin V Targeting NETs Formation